Cochrane · systematic review · CD002151
Antipyretic measures for treating fever in malaria
Meremikwu, MM, Odigwe, CC, Akudo Nwagbara, B, et al. · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library
Infectious DiseasesAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
2
No studies
1
Included studies
NR
No studies 1 · 33.3%Ungraded 0 · 0%Very low 2 · 66.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Antipyretic drugs compared to no antipyretic drug or placebo for treating fever in malaria
Population: patients with fever in malaria
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
FCT Antipyretic drugs vs no antipyretic drug or placebo | no estimate extracted | 2 studies · 59 participants | Very low Downgraded: risk of bias, publication bias |
PCT Antipyretic drugs vs no antipyretic drug or placebo | no estimate extracted | 2 studies · 59 participants | Very low Downgraded: risk of bias |
Adverse Events Antipyretic drugs vs no antipyretic drug or placebo | no estimate extracted | NR | No studies |